These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 8314017)

  • 21. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model.
    O'Brien BA; Harmon BV; Cameron DP; Allan DJ
    J Pathol; 1996 Feb; 178(2):176-81. PubMed ID: 8683386
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of tolerance in murine autoimmune diabetes by transient blockade of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 pathway.
    Moriyama H; Yokono K; Amano K; Nagata M; Hasegawa Y; Okamoto N; Tsukamoto K; Miki M; Yoneda R; Yagi N; Tominaga Y; Kikutani H; Hioki K; Okumura K; Yagita H; Kasuga M
    J Immunol; 1996 Oct; 157(8):3737-43. PubMed ID: 8871677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A mechanism for IL-10-mediated diabetes in the nonobese diabetic (NOD) mouse: ICAM-1 deficiency blocks accelerated diabetes.
    Balasa B; La Cava A; Van Gunst K; Mocnik L; Balakrishna D; Nguyen N; Tucker L; Sarvetnick N
    J Immunol; 2000 Dec; 165(12):7330-7. PubMed ID: 11120869
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acceleration of autoimmune diabetes by cyclophosphamide is associated with an enhanced IFN-gamma secretion pathway.
    Ablamunits V; Quintana F; Reshef T; Elias D; Cohen IR
    J Autoimmun; 1999 Dec; 13(4):383-92. PubMed ID: 10585754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice.
    Shultz LD; Schweitzer PA; Christianson SW; Gott B; Schweitzer IB; Tennent B; McKenna S; Mobraaten L; Rajan TV; Greiner DL
    J Immunol; 1995 Jan; 154(1):180-91. PubMed ID: 7995938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of STZ administration on islet isograft and allograft survival in NOD mice.
    Takayama Y; Ichikawa T; Maki T
    Diabetes; 1993 Feb; 42(2):324-9. PubMed ID: 8425668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GLUT2 in pancreatic islets: crucial target molecule in diabetes induced with multiple low doses of streptozotocin in mice.
    Wang Z; Gleichmann H
    Diabetes; 1998 Jan; 47(1):50-6. PubMed ID: 9421374
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD8 cytotoxic T-cell clone rapidly transfers autoimmune diabetes in very young NOD and MHC class I-compatible scid mice.
    Yoneda R; Yokono K; Nagata M; Tominaga Y; Moriyama H; Tsukamoto K; Miki M; Okamoto N; Yasuda H; Amano K; Kasuga M
    Diabetologia; 1997 Sep; 40(9):1044-52. PubMed ID: 9300241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Streptozotocin is equally diabetogenic whether administered to fed or fasted mice.
    Chaudhry ZZ; Morris DL; Moss DR; Sims EK; Chiong Y; Kono T; Evans-Molina C
    Lab Anim; 2013 Oct; 47(4):257-65. PubMed ID: 23760565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of schistosoma mansoni egg deposition on multiple low doses streptozotocin induced insulin dependent diabetes.
    El-Wakil HS; Aboushousha TS; El Haddad O; Gamil NB; Mansour T; El-Said H
    J Egypt Soc Parasitol; 2002 Dec; 32(3):987-1002. PubMed ID: 12512830
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NO-mediated cytotoxicity contributes to multiple low-dose streptozotocin-induced diabetes but not to NOD diabetes.
    Yasuda H; Jin Z; Nakayama M; Yamada K; Kishi M; Okumachi Y; Arai T; Moriyama H; Yokono K; Nagata M
    Diabetes Res Clin Pract; 2009 Feb; 83(2):200-7. PubMed ID: 19117633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The thymus as a site for evaluating the potency of candidate beta cell autoantigens in NOD mice.
    Gerling IC; Atkinson MA; Leiter EH
    J Autoimmun; 1994 Dec; 7(6):851-8. PubMed ID: 7888041
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of thymic immunity and insulitis in the development of streptozocin-induced diabetes in mice.
    Nakamura M; Nagafuchi S; Yamaguchi K; Takaki R
    Diabetes; 1984 Sep; 33(9):894-900. PubMed ID: 6236118
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model.
    Marzo N; Ortega S; Stratmann T; García A; Ríos M; Giménez A; Gomis R; Mora C
    J Immunol; 2008 Jan; 180(2):1189-98. PubMed ID: 18178859
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoimmune diabetes induced by the beta-cell toxin STZ. Immunity to the 60-kDa heat shock protein and to insulin.
    Elias D; Prigozin H; Polak N; Rapoport M; Lohse AW; Cohen IR
    Diabetes; 1994 Aug; 43(8):992-8. PubMed ID: 8039607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrathymic islet cell transplantation reduces beta-cell autoimmunity and prevents diabetes in NOD/Lt mice.
    Gerling IC; Serreze DV; Christianson SW; Leiter EH
    Diabetes; 1992 Dec; 41(12):1672-6. PubMed ID: 1446808
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presented antigen from damaged pancreatic beta cells activates autoreactive T cells in virus-mediated autoimmune diabetes.
    Horwitz MS; Ilic A; Fine C; Rodriguez E; Sarvetnick N
    J Clin Invest; 2002 Jan; 109(1):79-87. PubMed ID: 11781353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD4+CD25+ regulatory T cells control the progression from periinsulitis to destructive insulitis in murine autoimmune diabetes.
    Ott PA; Anderson MR; Tary-Lehmann M; Lehmann PV
    Cell Immunol; 2005 May; 235(1):1-11. PubMed ID: 16122720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.
    Stosic-Grujicic S; Stojanovic I; Maksimovic-Ivanic D; Momcilovic M; Popadic D; Harhaji L; Miljkovic D; Metz C; Mangano K; Papaccio G; Al-Abed Y; Nicoletti F
    J Cell Physiol; 2008 Jun; 215(3):665-75. PubMed ID: 18064633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.